Bay Street News, March, 2020

CAMBRIDGE, Mass., March 20, 2020 (GLOBE NEWSWIRE) — Unum Therapeutics Inc. (NASDAQ: UMRX), a biopharmaceutical company focused on developing curative […]

TORONTO, March 20, 2020 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company”) announces certain […]

NEW YORK, March 20, 2020 (GLOBE NEWSWIRE) — iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”), a biologics contract manufacturing […]

LONDON, March 20, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on […]

LAUSANNE, Switzerland, March 20, 2020 (GLOBE NEWSWIRE) — AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a […]

– Commits to keeping clinics open when and where possible during the crisis –– Withdrawing financial and clinic opening guidance […]

Randomizations concluded and trial participation in process of concluding to ensure patient safety during COVID-19 pandemicAXS-05 and placebo arms fully […]

COVIDTRAPTM is a proprietary ACE2-Fc protein that binds to the S1 domain of the spike protein of the SARS-CoV-2 virus;COVIDTRAP […]

SOUTH SAN FRANCISCO, Calif., March 20, 2020 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on […]

Maroussi, Greece, March 20, 2020 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), (the “Company” or “Pyxis Tankers”) a growth-oriented […]